BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stagg J. Mesenchymal stem cells in cancer. Stem Cell Rev. 2008;4:119-124. [PMID: 18493880 DOI: 10.1007/s12015-008-9030-4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Hervy M, Weber JL, Pecheul M, Dolley-Sonneville P, Henry D, Zhou Y, Melkoumian Z. Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions. PLoS One 2014;9:e92120. [PMID: 24638103 DOI: 10.1371/journal.pone.0092120] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
2 Ungaro F, D'Alessio S, Danese S. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies. Cancers (Basel) 2020;12:E2060. [PMID: 32722560 DOI: 10.3390/cancers12082060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wong RSY, Cheong S. Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde? Clin Exp Med 2014;14:235-48. [DOI: 10.1007/s10238-013-0247-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tan X, Gong YZ, Wu P, Liao DF, Zheng XL. Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy. Int J Mol Sci 2014;15:14348-63. [PMID: 25196436 DOI: 10.3390/ijms150814348] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
5 Luo Y, Wang B, Liu J, Ma F, Luo D, Zheng Z, Lu Q, Zhou W, Zheng Y, Zhang C, Wang Q, Sha W, Chen H. Ginsenoside RG1 enhances the paracrine effects of bone marrow-derived mesenchymal stem cells on radiation induced intestinal injury. Aging (Albany NY) 2020;13:1132-52. [PMID: 33293477 DOI: 10.18632/aging.202241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ding DC, Liu HW, Chu TY. Interleukin-6 from Ovarian Mesenchymal Stem Cells Promotes Proliferation, Sphere and Colony Formation and Tumorigenesis of an Ovarian Cancer Cell Line SKOV3. J Cancer 2016;7:1815-23. [PMID: 27698921 DOI: 10.7150/jca.16116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
7 Sanchez LR, Borriello L, Entenberg D, Condeelis JS, Oktay MH, Karagiannis GS. The emerging roles of macrophages in cancer metastasis and response to chemotherapy. J Leukoc Biol 2019;106:259-74. [PMID: 30720887 DOI: 10.1002/JLB.MR0218-056RR] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
8 Mathonnet M, Perraud A, Christou N, Akil H, Melin C, Battu S, Jauberteau MO, Denizot Y. Hallmarks in colorectal cancer: Angiogenesis and cancer stem-like cells. World J Gastroenterol 2014; 20(15): 4189-4196 [PMID: 24764657 DOI: 10.3748/wjg.v20.i15.4189] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 54] [Article Influence: 7.5] [Reference Citation Analysis]
9 Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, Mo YY, Xu R, Liu Y, Watabe K, Vemuri MC, Pochampally R. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget 2015;6:4953-67. [PMID: 25669974 DOI: 10.18632/oncotarget.3211] [Cited by in Crossref: 178] [Cited by in F6Publishing: 181] [Article Influence: 29.7] [Reference Citation Analysis]
10 Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA. 2008;105:14638-14643. [PMID: 18794523 DOI: 10.1073/pnas.0803670105] [Cited by in Crossref: 292] [Cited by in F6Publishing: 287] [Article Influence: 20.9] [Reference Citation Analysis]
11 Fakiruddin KS, Baharuddin P, Lim MN, Fakharuzi NA, Yusof NA, Zakaria Z. Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells. Cancer Cell Int. 2014;14:122. [PMID: 25469108 DOI: 10.1186/s12935-014-0122-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao Q, Hu J, Xiang J, Gu Y, Jin P, Hua F, Zhang Z, Liu Y, Zan K, Zhang Z, Zu J, Yang X, Shi H, Zhu J, Xu Y, Cui G, Ye X. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Res 2015;1624:489-96. [PMID: 26279113 DOI: 10.1016/j.brainres.2015.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
13 Fakiruddin KS, Ghazalli N, Lim MN, Zakaria Z, Abdullah S. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour. Int J Mol Sci 2018;19:E2188. [PMID: 30060445 DOI: 10.3390/ijms19082188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
14 Meleshina AV, Cherkasova EI, Shirmanova MV, Klementieva NV, Kiseleva EV, Snopova LВ, Prodanets NN, Zagaynova EV. Influence of mesenchymal stem cells on metastasis development in mice in vivo. Stem Cell Res Ther 2015;6:15. [PMID: 25888992 DOI: 10.1186/s13287-015-0003-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
15 Galland S, Martin P, Fregni G, Letovanec I, Stamenkovic I. Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins. Cancer Lett 2020;484:50-64. [PMID: 32418888 DOI: 10.1016/j.canlet.2020.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Bhang SH, Lee S, Shin JY, Lee TJ, Jang HK, Kim BS. Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis. Mol Ther. 2014;22:862-872. [PMID: 24413377 DOI: 10.1038/mt.2013.301] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
17 Ehnert S, Glanemann M, Schmitt A, Vogt S, Shanny N, Nussler NC, Stöckle U, Nussler A. The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg. 2009;394:985-997. [PMID: 19644703 DOI: 10.1007/s00423-009-0546-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
18 Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010;9:129. [PMID: 20509882 DOI: 10.1186/1476-4598-9-129] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 11.7] [Reference Citation Analysis]
19 Baxter-Holland M, Dass CR. Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use. J Pharm Pharmacol 2018;70:320-7. [PMID: 29355940 DOI: 10.1111/jphp.12869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
20 Brenner AK, Andersson Tvedt TH, Bruserud Ø. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells. Molecules 2016;21:E1512. [PMID: 27845732 DOI: 10.3390/molecules21111512] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
21 Huang WH, Chang MC, Tsai KS, Hung MC, Chen HL, Hung SC. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene. 2013;32:4343-4354. [PMID: 23085755 DOI: 10.1038/onc.2012.458] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 12.2] [Reference Citation Analysis]
22 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Reference Citation Analysis]
23 Fu FF, Zhu XJ, Wang HX, Zhang LM, Yuan GL, Chen ZC, Li QB. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro. Acta Pharmacol Sin 2017;38:1475-85. [PMID: 28836580 DOI: 10.1038/aps.2017.116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells: Cell Surface Markers and Exogenously Induced PpIX. Cytometry 2015;87:1001-11. [DOI: 10.1002/cyto.a.22781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Vallabhaneni KC, Penfornis P, Xing F, Hassler Y, Adams KV, Mo YY, Watabe K, Pochampally R. Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway. Oncotarget 2017;8:109861-76. [PMID: 29299114 DOI: 10.18632/oncotarget.22371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
26 Cho YJ, Song HS, Bhang S, Lee S, Kang BG, Lee JC, An J, Cha CI, Nam DH, Kim BS, Joo KM. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012;90:1794-802. [PMID: 22535477 DOI: 10.1002/jnr.23063] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
27 Nakayama K, Nakayama N, Katagiri H, Miyazaki K. Mechanisms of ovarian cancer metastasis: biochemical pathways.Int J Mol Sci. 2012;13:11705-11717. [PMID: 23109879 DOI: 10.3390/ijms130911705] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
28 Shi Y, Du L, Lin L, Wang Y. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2017;16:35-52. [PMID: 27811929 DOI: 10.1038/nrd.2016.193] [Cited by in Crossref: 189] [Cited by in F6Publishing: 191] [Article Influence: 31.5] [Reference Citation Analysis]
29 El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev 2014;20:523-44. [PMID: 24552279 DOI: 10.1089/ten.TEB.2013.0664] [Cited by in Crossref: 142] [Cited by in F6Publishing: 135] [Article Influence: 17.8] [Reference Citation Analysis]
30 Karagiannis GS, Condeelis JS, Oktay MH. Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin Exp Metastasis 2018;35:269-84. [PMID: 29307118 DOI: 10.1007/s10585-017-9870-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
31 Fang S, Salven P. Stem cells in tumor angiogenesis. Journal of Molecular and Cellular Cardiology 2011;50:290-5. [DOI: 10.1016/j.yjmcc.2010.10.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
32 Chen DR, Lu DY, Lin HY, Yeh WL. Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer. Biomed Res Int 2014;2014:532161. [PMID: 25140317 DOI: 10.1155/2014/532161] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
33 Kumar S, Verma R, Tyagi N, Gangenahalli G, Verma YK. Therapeutics effect of mesenchymal stromal cells in reactive oxygen species-induced damages. Hum Cell 2021. [PMID: 34800267 DOI: 10.1007/s13577-021-00646-5] [Reference Citation Analysis]
34 Hung SP, Yang MH, Tseng KF, Lee OK. Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant 2013;22:1869-82. [PMID: 23067574 DOI: 10.3727/096368912X657954] [Cited by in Crossref: 73] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
35 Mehrabadi S, Motevaseli E, Sadr SS, Moradbeygi K. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer's disease rats. Behav Brain Res. 2020;379:112362. [PMID: 31739000 DOI: 10.1016/j.bbr.2019.112362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
36 Huang R, Wu D, Yuan Y, Li X, Holm R, Trope CG, Nesland JM, Suo Z. CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients. PLoS One 2014;9:e112209. [PMID: 25380303 DOI: 10.1371/journal.pone.0112209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
37 Kleinschmidt K, Klinge PM, Stopa E, Wallrapp C, Glage S, Geigle P, Brinker T. Alginate encapsulated human mesenchymal stem cells suppress syngeneic glioma growth in the immunocompetent rat. Journal of Microencapsulation 2011;28:621-7. [DOI: 10.3109/02652048.2011.599441] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
38 Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91:411-429. [PMID: 23515621 DOI: 10.1007/s00109-013-1021-5] [Cited by in Crossref: 221] [Cited by in F6Publishing: 201] [Article Influence: 24.6] [Reference Citation Analysis]
39 Rodriguez R, Rubio R, Menendez P. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res 2012;22:62-77. [PMID: 21931359 DOI: 10.1038/cr.2011.157] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 9.0] [Reference Citation Analysis]
40 Kim SM, Kang SG, Park NR, Mok HS, Huh YM, Lee SJ, Jeun SS, Hong YK, Park CK, Lang FF. Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst 2011;27:911-22. [PMID: 21298274 DOI: 10.1007/s00381-011-1396-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
41 Sasikala M, Surya P, Radhika G, Kumar PP, Rao MS, Mukherjee RM, Rao PN, Reddy DN. Identification of circulating CD90+ CD73+ cells in cirrhosis of liver. World J Stem Cells 2011; 3(7): 63-69 [PMID: 21860671 DOI: 10.4252/wjsc.v3.i7.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Khan RS, Newsome PN. A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells. Front Immunol 2019;10:1952. [PMID: 31555259 DOI: 10.3389/fimmu.2019.01952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
43 Mcduffee LA, Pack L, Lores M, Wright GM, Esparza-gonzalez B, Masaoud E. Osteoprogenitor Cell Therapy in an Equine Fracture Model: Osteoprogenitor Cell Therapy. Veterinary Surgery 2012;41:773-83. [DOI: 10.1111/j.1532-950x.2012.01024.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Liu J, Zhang Y, Bai L, Cui X, Zhu J. Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells: MALIGNANT TRANSFORMATION OF MSCS. Cell Biochem Funct 2012;30:650-6. [DOI: 10.1002/cbf.2844] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
45 Toledano Furman NE, Lupu-haber Y, Bronshtein T, Kaneti L, Letko N, Weinstein E, Baruch L, Machluf M. Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform. Nano Lett 2013;13:3248-55. [DOI: 10.1021/nl401376w] [Cited by in Crossref: 151] [Cited by in F6Publishing: 151] [Article Influence: 16.8] [Reference Citation Analysis]
46 Chen J, Ren Q, Cai Y, Lin T, Zuo W, Wang J, Lin R, Zhu L, Wang P, Dong H, Zhao H, Huang L, Fu Y, Yang S, Tan J, Lan X, Wang S. Mesenchymal stem cells drive paclitaxel resistance in ErbB2/ErbB3-coexpressing breast cancer cells via paracrine of neuregulin 1. Biochemical and Biophysical Research Communications 2018;501:212-9. [DOI: 10.1016/j.bbrc.2018.04.218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
47 Ljujic B, Milovanovic M, Volarevic V, Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML, Stojkovic M. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep 2013;3:2298. [PMID: 23892388 DOI: 10.1038/srep02298] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
48 Dehaini D, Fang RH, Zhang L. Biomimetic strategies for targeted nanoparticle delivery. Bioeng Transl Med 2016;1:30-46. [PMID: 29313005 DOI: 10.1002/btm2.10004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 11.5] [Reference Citation Analysis]
49 Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011;32:964-72. [PMID: 21317300 DOI: 10.1093/carcin/bgr029] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 6.5] [Reference Citation Analysis]
50 Jia R, Zhao H, Wang S. Neuregulin Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1270:1-29. [PMID: 33123990 DOI: 10.1007/978-3-030-47189-7_1] [Reference Citation Analysis]
51 Droeser RA, Mechera R, Däster S, Weixler B, Kraljević M, Delko T, Güth U, Stadlmann S, Terracciano L, Singer G. MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity. BMC Cancer 2016;16:639. [PMID: 27531373 DOI: 10.1186/s12885-016-2673-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chang PY, Qu YQ, Wang J, Dong LH. The potential of mesenchymal stem cells in the management of radiation enteropathy. Cell Death Dis. 2015;6:e1840. [PMID: 26247725 DOI: 10.1038/cddis.2015.189] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
53 Droeser RA, Güth U, Eppenberger-castori S, Stadlmann S, Hirt C, Terracciano L, Singer G. High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma. J Cancer Res Clin Oncol 2013;139:1295-302. [DOI: 10.1007/s00432-013-1441-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
54 Norozi F, Ahmadzadeh A, Shahrabi S, Vosoughi T, Saki N. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells. Tumour Biol. 2016;37:11679-11689. [PMID: 27440203 DOI: 10.1007/s13277-016-5187-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
55 Kang SG, Shinojima N, Hossain A, Gumin J, Yong RL, Colman H, Marini F, Andreeff M, Lang FF. Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 2010;67:711-20. [PMID: 20651630 DOI: 10.1227/01.NEU.0000377859.06219.78] [Cited by in Crossref: 58] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
56 McGrail DJ, Ghosh D, Quach ND, Dawson MR. Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. PLoS One 2012;7:e33248. [PMID: 22438903 DOI: 10.1371/journal.pone.0033248] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
57 Rodríguez R, García-Castro J, Trigueros C, García Arranz M, Menéndez P. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Adv Exp Med Biol 2012;741:187-205. [PMID: 22457111 DOI: 10.1007/978-1-4614-2098-9_13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
58 Sioud M, Fløisand Y. NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation. Journal of Leukocyte Biology 2009;85:939-46. [DOI: 10.1189/jlb.1008650] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
59 Nassiri SM, Rahbarghazi R. Interactions of Mesenchymal Stem Cells with Endothelial Cells. Stem Cells and Development 2014;23:319-32. [DOI: 10.1089/scd.2013.0419] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
60 Letko Khait N, Malkah N, Kaneti G, Fried L, Cohen Anavy N, Bronshtein T, Machluf M. Radiolabeling of cell membrane-based nano-vesicles with 14C-linoleic acid for robust and sensitive quantification of their biodistribution. J Control Release 2019;293:215-23. [PMID: 30527755 DOI: 10.1016/j.jconrel.2018.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
61 Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, Tanasie G, Bunu C, Crisnic D, Gherghiceanu M. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med. 2011;15:635-646. [PMID: 20184663 DOI: 10.1111/j.1582-4934.2010.01044.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 131] [Article Influence: 9.0] [Reference Citation Analysis]
62 McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR. Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest. 2011;121:3206-3219. [PMID: 21737876 DOI: 10.1172/jci45273] [Cited by in Crossref: 222] [Cited by in F6Publishing: 171] [Article Influence: 20.2] [Reference Citation Analysis]
63 Li Y, Gao X, Wang J. Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model. Exp Ther Med 2018;15:1839-46. [PMID: 29434773 DOI: 10.3892/etm.2017.5606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
64 Sano M, Driscoll DR, De Jesus-Monge WE, Klimstra DS, Lewis BC. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms. Gastroenterology 2014;146:257-67. [PMID: 24067880 DOI: 10.1053/j.gastro.2013.09.044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
65 Rodriguez R, Rosu-Myles M, Aráuzo-Bravo M, Horrillo A, Pan Q, Gonzalez-Rey E, Delgado M, Menendez P. Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation. Stem Cell Reports 2014;3:606-19. [PMID: 25358789 DOI: 10.1016/j.stemcr.2014.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
66 Udartseva OO, Andreeva ER, Buravkova LB. Effects of photodynamic treatment on mesenchymal stromal cells. Dokl Biol Sci 2013;450:185-8. [PMID: 23821063 DOI: 10.1134/S0012496613030174] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
67 Lu HJ, Li J, Yang G, Yi CJ, Zhang D, Yu F, Ma Z. Circular RNAs in stem cells: from basic research to clinical implications. Biosci Rep 2022;42:BSR20212510. [PMID: 34908111 DOI: 10.1042/BSR20212510] [Reference Citation Analysis]